Evolution Biologyx is using the power of human evolution to develop products for the regenerative therapeutics market. Regenerative medicines involve healing wounds and replacing or supplementing damaged tissue. Evolution's innovative portfolio of products includes Interfyl®, a decellularized human placental connective tissue matrix that can be used to replace damaged tissue and Biovance®, a natural scaffold and protective cover for hard to heal, chronic wounds. All Evolution’s products are FDA-registered and manufactured to high quality. Evolution then works with practitioners so that the biologics can be delivered as natural and effective solutions.

Evolution Biologyx

Founded: 2020
Location: Center Valley, PA
Employee range: 1-50
Funding: not disclosed

Short description:

Drug notes:

Long description:

Jobs: